Comment
. 2007 Apr;137(1):78-9; author reply 79-80.
doi: 10.1111/j.1365-2141.2007.06529.x.
Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals
- PMID: 17359374
- DOI: 10.1111/j.1365-2141.2007.06529.x
Item in Clipboard
Comment
Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals
Br J Haematol.
2007 Apr.
Free article
No abstract available
Comment on
-
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.Br J Haematol. 2006 Dec;135(5):642-50. doi: 10.1111/j.1365-2141.2006.06312.x. Epub 2006 Oct 19. Br J Haematol. 2006. PMID: 17054431
-
Long-term safety of filgrastim (rhG-CSF) administration.Br J Haematol. 2007 Apr;137(1):77-8; author reply 79-80. doi: 10.1111/j.1365-2141.2007.06524.x. Br J Haematol. 2007. PMID: 17359373 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
